ANX-042

· Mayo Clinic

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ANX-042, covering 2017-10-13 to 2024-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome [Phase 1]